VAIA
BIO icon

Virtus Alternative Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11
Closed -$6K – 32
2020
Q4 		$6K Sell
11
-10
-48% -$5.7K 0.09% 175
2020
Q3 		$11K Sell
21
-13
-38% -$6.58K 0.2% 104
2020
Q2 		$15K Sell
34
-31
-48% -$13.7K 0.23% 118
2020
Q1 		$23K Buy
65
+40
+160% +$14.7K 0.32% 31
2019
Q4 		$9K Buy
+25
New +$8.81K 0.14% 79

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Virtus Alternative Investment Advisers's BIO Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 11 shares — an estimated $6K sold.

Virtus Alternative Investment Advisers first reported a position in BIO in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 11 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $6K.
  • Virtus Alternative Investment Advisers first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Bio-Rad Laboratories Class A position peaked at $23K in Q1 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.